Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:52:09.229Z.
Calculation as of: 2026-10-06T16:52:09.229Z.
Quote observation: 2026-10-06T16:49:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8
EARNINGS YIELD
N/A
Market Cap
$96.75M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$93.26M
Earnings Yield
N/A
TTM Avg
7.66%
3Y Avg
7.66%
5Y Avg
7.66%
Market Cap
$103.68M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $97.49M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.61M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.75M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.61M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.63M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.26M | N/A | 7.66% | 7.66% | 7.66% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.25M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.51M | 3.69% | 2.61% | 2.26% | 1.70% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute